Skip to content
DraconiticResearch
Search Sources API
220,595 studies31 sourcesUpdated 8 min ago

Oncology

5,778 studies502 in 7 days2,682 in 30 days

Filters
Type
Date
Clear

Latest

5,778 studies

  1. Characteristics of progressive multifocal leukoencephalopathy in hematological malignancies, With reference to HIV-infected patients
    Emi Yokoyama, Taisuke Harada, Tomoyuki Endo +14
    International Journal of HematologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  2. Association between pain, body mass index, and clinical characteristics in lipedema: Segmental analysis using bioimpedance
    Jubiza Pusic, Sofía Mora, Patricia Froes Meyer
    Journal of Vascular Surgery: Venous and Lymphatic DisordersPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  3. High PD-L1 Expression and Clinical Outcomes of First-Line Osimertinib in EGFR-Mutant NSCLC: A Multicenter Real-World Validation Study (WJOG 20724L)
    Yoshihiko Sakata, Kenta Murotani, Daichi Fujimoto +18
    JTO clinical and research reportsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  4. Mechanistic insights on mogrosides as bifunctional regulators of metabolic reprogramming and immune modulation in tumor microenvironment
    Meghna Patial, Rohit Joshi, Jyoti Rajput +4
    Cancer Immunology, Immunotherapy : CIIPeer-reviewedCC BY 4.0Full textOncologyPMC
  5. High PD-L1 Expression and Clinical Outcomes of First-Line Osimertinib in
    Yoshihiko Sakata, MD, Kenta Murotani, PhD, Daichi Fujimoto, MD, PhD +18
    JTO Clinical and Research ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyDOAJPMC
  6. Age-related survival gaps in triple-negative breast cancer: a 10-year real-world analysis.
    Dinis Galhardo, Bárbara Peleteiro, Fernando Osório
    Aging clinical and experimental researchPeer-reviewedCC BYFull textOncologyEurope PMC
  7. Multimodal ctDNA profiling for cancer detection and monitoring in pan-cancer patients with advanced disease enrolled in the SHI-VA02 trial
    K. Nedara, M. Gorse, K. von Grafenstein +12
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  8. Rethinking the Platinum Standard in SCLC: A Meta-Analysis of Limited- and Extensive-Stage Disease in the Immunotherapy Era
    Tomer Meirson, Hadas Ditzian Kugler, Ekaterina Hanovich +3
    JTO clinical and research reportsPeer-reviewedCC BYFull textOncologyEurope PMC
  9. A PTX3/TLR4 axis sustains sonic hedgehog-medulloblastoma growth and defines a new therapeutic vulnerability
    Serena Filiberti, Camilla Tavani, Elena Somenza +16
    Neuro-OncologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  10. Tissue-reactive zonation of mesenchymal-like phenotypes in human glioblastoma
    Alejandro Mossi Albiach, Jokubas Janusauskas, Jesper Kjaer Jacobsen +16
    MedPeer-reviewedCC BY29 citedHuman geneticsOncologyOpenAlex
  11. Mitochondrial metabolism determines chemotherapy sensitivity in colorectal cancer
    Deborah Y. Moss, Connor N. Brown, Andrew M. Shaw +46
    Nature MetabolismPeer-reviewedCC BYFull text12 citedOncologyOpenAlex
  12. Targeting minimal residual disease (MRD) in colorectal cancer: Therapeutic strategies, clinical trials, and the path toward molecular cure
    Yusuf Saleem Khan, Aisha Farhana, Hatim Adam Nagi +5
    Cancer pathogenesis and therapyPeer-reviewedCC BYFull textOncologyEurope PMCEurope PMCPMC
  13. The Y chromosome gene KDM5D restrains CD8+ T cell antitumor immunity through TCR and cholesterol-exhaustion programs
    J. Li, C. Y. Ching, A. Ben-Shmuel +19
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  14. Human rhinovirus 16 impairs macrophage cytokine secretion by disrupting NF-κB nuclear translocation and intracellular cytokine trafficking
    Zoé Fremont-Debaene, Zeyni Mansuroglu, Léane Puchot +5
    HALPreprintCC BY-NC-ND 4.0Full textOncologyHAL
  15. Epstein-Barr virus induced hyperbilirubinemia and jaundice: a case report
    Carly Perkowski, Rachel Cox, Kelsey Wilson
    BMC Infectious DiseasesPeer-reviewedCC BY 4.0Full textOncologyPMC
  16. Case Report: T‐Lymphoblastic Leukemia in a Dog With Erythrophagia
    Francisca B. Lang, Matheus Y. dos Santos, Vinicius N. Hirata +5
    Veterinary Clinical PathologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  17. Genetic and Pharmacologic Targeting of Eya3 in Macrophages Drives Anti-Tumor Immunity in Triple-Negative Breast Cancer
    K. M. Fields, G. Terue Rizzo Kodama, E. Danis +18
    bioRxivPreprintCC BYFull textOncologybioRxiv
  18. Pfannenstiel versus periumbilical specimen extraction in laparoscopic low anterior resection: a comparative analysis of incisional hernia risk, postoperative recovery, and oncologic outcomes.
    Seung Yeon Kang, Dong Hyun Shin, Hyeon Woo Bae +6
    Techniques in coloproctologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  19. Treatment patterns and outcomes in perineal primary vulvar cancer—a population‐based Swedish cohort study
    Karin Kjölhede, Gabriel Lindahl, Christian Staf +2
    Acta Obstetricia et Gynecologica ScandinavicaPeer-reviewedCC BY 4.0Full textOncologyPMCDOAJ
  20. Early increase in apparent diffusion coefficient predicts favorable response to dordaviprone (ONC201) therapy in H3K27M-mutant diffuse midline glioma
    Benison C Lau, Diala P Ajaero, Benjamin A Hoff +21
    Neuro-OncologyPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  21. High-throughput single-cell screening of a cross-lineage CAR library for early-stage CAR design and candidate discovery
    Hairong Jing, Dan Yuan, Bangquan Ye +9
    Communications BiologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  22. Survival after pulmonary metastasectomy for pancreatobiliary carcinomas: insights from a nationwide multicenter database
    Taisuke Kaiho, Takahide Toyoda, Hidemi Suzuki +16
    Surgery TodayPeer-reviewedCC BY 4.0Full textOncologyPMC
  23. Radiologic–pathologic discrepancy in the tumor size assessment of pancreatic ductal adenocarcinoma in the era of preoperative therapy
    Kazuki Kobayashi, Kaya Ijiri, Takazumi Tsunenari +7
    Surgery TodayPeer-reviewedCC BY 4.0Full textOncologyPMC
  24. Secondary breast surgery after initial partial mastectomy for breast cancer in Japan
    Munetsugu Hirata, Yuko Kijima, Sam E. Wing +2
    Surgery TodayPeer-reviewedCC BY 4.0Full textOncologyPMC
  25. Utilization of immune checkpoint inhibitors for the treatment of cancer in Scotland, 2018–2024: A national retrospective cohort study
    Tanja Mueller, Christine Crearie, Liya Lu +7
    British Journal of Clinical PharmacologyPeer-reviewedCC BY 4.0Full text1 citedOncologyPMC